WordNet
- a drug that neutralizes or counteracts the effects of another drug
- a muscle that relaxes while another contracts; "when bending the elbow the triceps are the antagonist"
- a cellular structure that is postulated to exist in order to mediate between a chemical agent that acts on nervous tissue and the physiological response
- any of several vasoconstrictor substances (trade name Hypertensin) that cause narrowing of blood vessels (同)angiotonin, Hypertensin
PrepTutorEJDIC
- 対立する人,敵対者,競争相手(opponent)
- =sense organ / 受信装置
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. アンギオテンシン変換酵素阻害剤およびアンギオテンシンII受容体拮抗剤の主な副作用 major side effects of angiotensin converting enzyme inhibitors and angiotensin ii receptor blockers
- 2. 収縮能障害による心不全におけるアンギオテンシンⅡ受容体拮抗剤およびネプリライシン阻害剤療法 angiotensin ii receptor blocker and neprilysin inhibitor therapy in heart failure due to systolic dysfunction
- 3. 高血圧治療におけるレニン・アンギオテンシン系阻害 renin angiotensin system inhibition in the treatment of hypertension
- 4. 原発性（本態性）高血圧における薬物療法の選択：推奨 choice of drug therapy in primary essential hypertension recommendations
- 5. 周産期心筋症：治療および予後 peripartum cardiomyopathy treatment and prognosis
English Journal
- Angiotensin II type 1 receptor blockade restores angiotensin-(1-7)-induced coronary vasodilation in hypertrophic rat hearts.
- Souza ÁP, Sobrinho DB, Almeida JF, Alves GM, Macedo LM, Porto JE, Vêncio EF, Colugnati DB, Santos RA, Ferreira AJ, Mendes EP, Castro CH.SourceDepartment of Physiological Sciences, Federal University of Goiás, Goiânia 74001-970, Brazil.
- Clinical science (London, England : 1979).Clin Sci (Lond).2013 Nov;125(9):449-59. doi: 10.1042/CS20120519.
- The aim of the present study was to investigate the coronary effects of Ang-(1-7) [angiotensin-(1-7)] in hypertrophic rat hearts. Heart hypertrophy was induced by abdominal aorta CoA (coarctation). Ang-(1-7) and AVE 0991, a non-peptide Mas-receptor agonist, at picomolar concentration, induced a sign
- PMID 23718715
- Acute regulation of pancreatic islet microcirculation and glycaemia by telmisartan and ramipril: discordant effects between normal and type 2 diabetic rats.
- Olverling A, Huang Z, Nyström T, Sjöholm Å.SourceDepartment of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, SE-118 83 Stockholm, Sweden.
- Clinical science (London, England : 1979).Clin Sci (Lond).2013 Nov;125(9):433-8. doi: 10.1042/CS20120635.
- Diabetic patients are often treated with an ACEi (angiotensin-converting enzyme inhibitor) or angiotensin receptor antagonist against hypertension or albuminuria. These drugs also have a positive impact on glucose tolerance, but the mechanism for this remains elusive. Hypothesizing a positive non-ad
- PMID 23713675
Japanese Journal
- 気管挿管管理を要したアンギオテンシン転換酵素阻害薬およびアンギオテンシンII受容体拮抗薬が原因と考えられた血管性浮腫の1例
- 米村 裕樹,今井 正之,新納 舞,宇田川 雅敏,横尾 聡
- 日本口腔科学会雑誌 64(3), 276-282, 2015
- … We report the case of a 62-year-old man with angioedema induced by an angiotensin-converting enzyme inhibitor (ACE inhibitor) and an angiotensin II receptor blocker (ARB) who required tracheal intubation management. … The patient had received an ACE inhibitor, an ARB and a Ca antagonist to treat hypertension. … Therapy with the ACE inhibitor and ARB was discontinued, switching to a Ca antagonist only. …
- NAID 130005100737
- A Study on the Occurrence and Prevention of Perioperative Stroke after Coronary Artery Bypass Grafting
- Sezai Akira,Nakata Kin-Ichi,Iida Mitsuru,Yoshitake Isamu,Wakui Shinji,Osaka Shunji,Kimura Haruka,Takahashi Kana,Ishi Yusuke,Yaoita Hiroko,Arimoto Munehito,Hata Hiroaki,Shiono Motomi,Takayama Tadateru,Hirayama Atsushi
- Annals of Thoracic and Cardiovascular Surgery 21(3), 275-281, 2015
- … The risk factors for postoperative atrial fibrillation were 75 or higher years of age, chronic kidney diseases, emergency surgery, cardiopulmonary bypass time >180 min, intraoperative carperitide non-use, intraoperative landiolol hydrochloride non-use, preoperative angiotensin II receptor blockers (ARB) non-use, preoperative calcium antagonist use, preoperative statin use, postoperative β-blocker non-use, and postoperative aldosterone blocker non-use. …
- NAID 130005083817
- A Study on the Occurrence and Prevention of Perioperative Stroke after Coronary Artery Bypass Grafting
- Sezai Akira,Nakata Kin-Ichi,Iida Mitsuru,Yoshitake Isamu,Wakui Shinji,Osaka Shunji,Kimura Haruka,Takahashi Kana,Ishi Yusuke,Yaoita Hiroko,Arimoto Munehito,Hata Hiroaki,Shiono Motomi,Takayama Tadateru,Hirayama Atsushi
- Annals of Thoracic and Cardiovascular Surgery advpub(0), 2015
- … The risk factors for postoperative atrial fibrillation were 75 or higher years of age, chronic kidney diseases, emergency surgery, cardiopulmonary bypass time >180 min, intraoperative carperitide non-use, intraoperative landiolol hydrochloride non-use, preoperative angiotensin II receptor blockers (ARB) non-use, preoperative calcium antagonist use, preoperative statin use, postoperative β-blocker non-use, and postoperative aldosterone blocker non-use. …
- NAID 130005074678
Related Links
- Angiotensin II receptor antagonists, also known as angiotensin receptor blockers (ARBs), AT1-receptor antagonists or sartans, are a group of pharmaceuticals which modulate the renin-angiotensin-aldosterone system. Their main uses are in ...
- Angiotensin II receptor blockers (angiotensin II inhibitors) treat conditions such as high blood pressure.
Related Pictures
★リンクテーブル★
| 関連記事 | 「angiotensin」 |
「angiotensin」